Cargando…
A Phase I/II study of vesigenurtacel-l (hs-410) or placebo in combination with Bacillus Calmette-Guérin (BCG) in patients with non-muscle invasive bladder cancer (NMIBC)
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288751/ http://dx.doi.org/10.1186/2051-1426-2-S3-P81 |
| _version_ | 1782352018439929856 |
|---|---|
| author | Steinberg, Gary D Shore, Neal Karsh, Lawrence Bailen, James Woods, Michael Schoenberg, Mark Schreiber, Taylor H Price, Melissa |
| author_facet | Steinberg, Gary D Shore, Neal Karsh, Lawrence Bailen, James Woods, Michael Schoenberg, Mark Schreiber, Taylor H Price, Melissa |
| author_sort | Steinberg, Gary D |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4288751 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2014 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-42887512015-01-15 A Phase I/II study of vesigenurtacel-l (hs-410) or placebo in combination with Bacillus Calmette-Guérin (BCG) in patients with non-muscle invasive bladder cancer (NMIBC) Steinberg, Gary D Shore, Neal Karsh, Lawrence Bailen, James Woods, Michael Schoenberg, Mark Schreiber, Taylor H Price, Melissa J Immunother Cancer Poster Presentation BioMed Central 2014-11-06 /pmc/articles/PMC4288751/ http://dx.doi.org/10.1186/2051-1426-2-S3-P81 Text en Copyright © 2014 Steinberg et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Poster Presentation Steinberg, Gary D Shore, Neal Karsh, Lawrence Bailen, James Woods, Michael Schoenberg, Mark Schreiber, Taylor H Price, Melissa A Phase I/II study of vesigenurtacel-l (hs-410) or placebo in combination with Bacillus Calmette-Guérin (BCG) in patients with non-muscle invasive bladder cancer (NMIBC) |
| title | A Phase I/II study of vesigenurtacel-l (hs-410) or placebo in combination with Bacillus Calmette-Guérin (BCG) in patients with non-muscle invasive bladder cancer (NMIBC) |
| title_full | A Phase I/II study of vesigenurtacel-l (hs-410) or placebo in combination with Bacillus Calmette-Guérin (BCG) in patients with non-muscle invasive bladder cancer (NMIBC) |
| title_fullStr | A Phase I/II study of vesigenurtacel-l (hs-410) or placebo in combination with Bacillus Calmette-Guérin (BCG) in patients with non-muscle invasive bladder cancer (NMIBC) |
| title_full_unstemmed | A Phase I/II study of vesigenurtacel-l (hs-410) or placebo in combination with Bacillus Calmette-Guérin (BCG) in patients with non-muscle invasive bladder cancer (NMIBC) |
| title_short | A Phase I/II study of vesigenurtacel-l (hs-410) or placebo in combination with Bacillus Calmette-Guérin (BCG) in patients with non-muscle invasive bladder cancer (NMIBC) |
| title_sort | phase i/ii study of vesigenurtacel-l (hs-410) or placebo in combination with bacillus calmette-guérin (bcg) in patients with non-muscle invasive bladder cancer (nmibc) |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288751/ http://dx.doi.org/10.1186/2051-1426-2-S3-P81 |
| work_keys_str_mv | AT steinberggaryd aphaseiiistudyofvesigenurtacellhs410orplaceboincombinationwithbacilluscalmetteguerinbcginpatientswithnonmuscleinvasivebladdercancernmibc AT shoreneal aphaseiiistudyofvesigenurtacellhs410orplaceboincombinationwithbacilluscalmetteguerinbcginpatientswithnonmuscleinvasivebladdercancernmibc AT karshlawrence aphaseiiistudyofvesigenurtacellhs410orplaceboincombinationwithbacilluscalmetteguerinbcginpatientswithnonmuscleinvasivebladdercancernmibc AT bailenjames aphaseiiistudyofvesigenurtacellhs410orplaceboincombinationwithbacilluscalmetteguerinbcginpatientswithnonmuscleinvasivebladdercancernmibc AT woodsmichael aphaseiiistudyofvesigenurtacellhs410orplaceboincombinationwithbacilluscalmetteguerinbcginpatientswithnonmuscleinvasivebladdercancernmibc AT schoenbergmark aphaseiiistudyofvesigenurtacellhs410orplaceboincombinationwithbacilluscalmetteguerinbcginpatientswithnonmuscleinvasivebladdercancernmibc AT schreibertaylorh aphaseiiistudyofvesigenurtacellhs410orplaceboincombinationwithbacilluscalmetteguerinbcginpatientswithnonmuscleinvasivebladdercancernmibc AT pricemelissa aphaseiiistudyofvesigenurtacellhs410orplaceboincombinationwithbacilluscalmetteguerinbcginpatientswithnonmuscleinvasivebladdercancernmibc AT steinberggaryd phaseiiistudyofvesigenurtacellhs410orplaceboincombinationwithbacilluscalmetteguerinbcginpatientswithnonmuscleinvasivebladdercancernmibc AT shoreneal phaseiiistudyofvesigenurtacellhs410orplaceboincombinationwithbacilluscalmetteguerinbcginpatientswithnonmuscleinvasivebladdercancernmibc AT karshlawrence phaseiiistudyofvesigenurtacellhs410orplaceboincombinationwithbacilluscalmetteguerinbcginpatientswithnonmuscleinvasivebladdercancernmibc AT bailenjames phaseiiistudyofvesigenurtacellhs410orplaceboincombinationwithbacilluscalmetteguerinbcginpatientswithnonmuscleinvasivebladdercancernmibc AT woodsmichael phaseiiistudyofvesigenurtacellhs410orplaceboincombinationwithbacilluscalmetteguerinbcginpatientswithnonmuscleinvasivebladdercancernmibc AT schoenbergmark phaseiiistudyofvesigenurtacellhs410orplaceboincombinationwithbacilluscalmetteguerinbcginpatientswithnonmuscleinvasivebladdercancernmibc AT schreibertaylorh phaseiiistudyofvesigenurtacellhs410orplaceboincombinationwithbacilluscalmetteguerinbcginpatientswithnonmuscleinvasivebladdercancernmibc AT pricemelissa phaseiiistudyofvesigenurtacellhs410orplaceboincombinationwithbacilluscalmetteguerinbcginpatientswithnonmuscleinvasivebladdercancernmibc |